• 1. An aquatic host–guest complex between a supramolecular G-quadruplex and the anticancer drug doxorubicin?
  José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565
• 2. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 3. Alumina grafted SBA-15 sustainable bifunctional catalysts for direct cross-coupling of benzylic alcohols to diarylmethanes?
  Chandran Rajendran,Govindaswamy Satishkumar,Charlotte Lang,Eric M. Gaigneaux Catal. Sci. Technol., 2020,10, 2583-2592
• 4. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 5. An insight into the role of side chains in the microstructure and carrier mobility of high-performance conjugated polymers?
  Jianyao Huang,Dong Gao,Zhihui Chen,Weifeng Zhang Polym. Chem., 2021,12, 2471-2480

Professional Introduction to N-methyl-1-(1-methylpiperidin-2-yl)methanamine (CAS No. 184637-50-1)

N-methyl-1-(1-methylpiperidin-2-yl)methanamine, a compound with the chemical identifier CAS No. 184637-50-1, is a significant molecule in the realm of pharmaceutical chemistry and medicinal research. This compound belongs to a class of organic molecules characterized by its intricate structural framework, which includes a piperidine ring and an amine functional group. The presence of these structural motifs makes it a compound of considerable interest for researchers exploring novel pharmacophores and potential therapeutic agents.

The molecular structure of N-methyl-1-(1-methylpiperidin-2-yl)methanamine is composed of a central carbon atom bonded to a methyl group, a piperidine ring substituted with another methyl group at the 1-position, and an amine group at the 2-position. This configuration imparts unique electronic and steric properties to the molecule, which can be exploited in drug design. The piperidine moiety is particularly noteworthy, as it is a common scaffold in many biologically active compounds, often contributing to interactions with biological targets such as enzymes and receptors.

In recent years, there has been growing interest in the development of small molecules that can modulate neurological pathways. The structural features of N-methyl-1-(1-methylpiperidin-2-yl)methanamine suggest potential applications in this area. Specifically, the piperidine ring can interact with various neurotransmitter receptors, making it a candidate for drugs targeting conditions such as depression, anxiety, and neurodegenerative disorders. Preliminary studies have indicated that derivatives of this compound may exhibit pharmacological activity by influencing neurotransmitter release or receptor binding.

The synthesis of N-methyl-1-(1-methylpiperidin-2-yl)methanamine involves multi-step organic reactions that require careful optimization to ensure high yield and purity. Common synthetic routes include nucleophilic substitution reactions, reductive amination, and cyclization processes. The choice of starting materials and reaction conditions can significantly impact the efficiency of the synthesis. Advanced techniques such as flow chemistry have also been explored to improve scalability and reproducibility in the production of this compound.

One of the key challenges in working with N-methyl-1-(1-methylpiperidin-2-yl)methanamine is its potential sensitivity to environmental factors such as moisture and light. Therefore, storage conditions must be carefully controlled to maintain stability. In laboratory settings, this compound is typically handled under inert atmospheres using appropriate protective equipment. These precautions are essential not only for ensuring the integrity of the sample but also for protecting researchers from any unintended exposure.

The pharmacological profile of N-methyl-1-(1-methylpiperidin-2-yl)methanamine has been the subject of several recent studies. Researchers have been particularly interested in its interactions with monoamine oxidase (MAO) enzymes, which are crucial in regulating neurotransmitter levels in the brain. In vitro studies have shown that certain derivatives of this compound can inhibit MAO activity, suggesting potential therapeutic benefits for disorders associated with neurotransmitter imbalances.

In addition to its pharmacological properties, N-methyl-1-(1-methylpiperidin-2-yl)methanamine has also attracted attention for its role as an intermediate in the synthesis of more complex molecules. Its structural versatility allows it to serve as a building block for designing novel compounds with tailored biological activities. This has opened up new avenues for drug discovery and development, particularly in areas where precise molecular modifications are required.

The computational modeling of N-methyl-1-(1-methylpiperidin-2-yl)methanamine has played a crucial role in understanding its behavior at both molecular and cellular levels. Techniques such as molecular dynamics simulations and quantum mechanical calculations have provided valuable insights into its interactions with biological targets. These computational approaches are complemented by experimental data obtained through spectroscopic methods like nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS), which help confirm the structural integrity and purity of the compound.

The future prospects for N-methyl-1-(1-methylpiperidin-2-yl)methanamine are promising, with ongoing research aimed at expanding its applications in pharmaceuticals and biotechnology. Innovations in synthetic methodologies may further enhance its accessibility and utility, while continued exploration of its pharmacological properties could lead to new therapeutic interventions. As our understanding of biological systems grows more sophisticated, compounds like this will remain indispensable tools in the quest to develop safer and more effective treatments for human diseases.

• 112419-07-5((2S)-N,N-dimethyl-2-Piperidinemethanamine)
• 901585-93-1(N-methyl-1-[1-(1-methylethyl)piperidin-2-yl]methanamine)
• 81310-55-6(1-(Piperidin-2-ylmethyl)piperidine)
• 857373-37-6(1-Isopropylpiperidin-3-amine)
• 1248952-99-9(N-ethyl-1-methylpiperidin-3-amine)
• 60717-51-3(N,N-dimethyl-1-(piperidin-2-yl)methanamine)
• 66300-62-7(N-[(1-methylpiperidin-2-yl)methyl]ethanamine)
• 61134-90-5(1,5-Naphthyridine, decahydro-1,5-dimethyl-)
• 3115-11-5(N'-[(1,6-dimethylpiperidin-2-yl)methyl]-N,N-diethylethane-1,2-diamine)
• 37782-46-0((1-ethylpiperidin-2-yl)methylamine)